Regulatory mechanisms and their therapeutic implications of interleukin-12 production in immune cells
- 30 June 2005
- journal article
- review article
- Published by Elsevier in Cellular Signalling
- Vol. 17 (6) , 665-673
- https://doi.org/10.1016/j.cellsig.2004.12.010
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Inhibiting cytokines of the interleukin-12 family: recent advances and novel challengesJournal of Pharmacy and Pharmacology, 2004
- Interleukin-12 and the regulation of innate resistance and adaptive immunityNature Reviews Immunology, 2003
- IL-12 Plays a Pathologic Role at the Inflammatory Loci in the Development of Diabetes in NOD MiceJournal of Autoimmunity, 2001
- THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune ResponsesAnnual Review of Immunology, 1998
- Suppression of IL-12 production by phosphodiesterase inhibition in murine endotoxemia is IL-10 independentEuropean Journal of Immunology, 1998
- Interleukin-12 Gene-Expression of Macrophages Is Regulated by Nitric OxideBiochemical and Biophysical Research Communications, 1996
- Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4.The Journal of Experimental Medicine, 1995
- Mouse interleukin‐12 (IL‐12) p40 homodimer: a potent IL‐12 antagonistEuropean Journal of Immunology, 1995
- Interleukin 12 at the site of disease in tuberculosis.Journal of Clinical Investigation, 1994
- Assignment of genes encoding a unique cytokine (IL12) composed of two unrelated subunits to chromosomes 3 and 5Genomics, 1992